Actively Recruiting
A Prospective Randomized Controlled Trial Comparing Duramesh14 With Polydioxanone Suture for Laparotomy Closure
Led by University Hospital, Ghent · Updated on 2025-04-17
230
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are comparing two methods for closing the abdomen after laparotomy surgery: Duramesh and polydioxanone sutures (PDS). The goal is to see if Duramesh is not worse than PDS for early surgical site events within one month after surgery and if it is better at preventing incisional hernias within one year. This study also looks at device performance, technical success of the surgery, pain, implant sensation, satisfaction of both patients and surgeons, and quality of life over 12 months. Participants will have their abdominal incision closed using either Duramesh, a device that combines mesh repair and suturing precision, or standard PDS sutures. Duramesh is designed to reduce surgical site events by distributing forces and allowing tissue growth into the repair. The study uses size 1 Duramesh, which is CE-marked, while the comparison group uses 2-0, 0, or number 1 PDS sutures. The study is randomized, with procedures performed during laparotomy surgery, and follow-up evaluations occur at 1 and 12 months after surgery. During the study, participants will be assessed for surgical site events, including wound problems and hernia occurrence, at various times up to 12 months. Researchers will evaluate pain using a numeric rating scale, implant sensation, and satisfaction from both patients and surgeons using 5-point scales. Quality of life will be measured with a health survey at 12 months. Safety, device performance, and any need for additional surgeries related to the device will also be monitored throughout the year-long follow-up.
CONDITIONS
Brief Title
Duramesh™ vs Polydioxanone Suture for Laparotomy Closure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or greater
- Abdominal laparotomy incision 5 cm or longer, midline or non-midline
- Isolated ostomy site takedown with or without parastomal hernia
- Patient accepts participation and gives informed consent
- Patient and investigator signed and dated the informed consent form prior to the index-procedure
You will not qualify if you...
- Pregnancy
- Clinically recognized hernia at laparotomy site (except parastomal hernia at ostomy site takedown and small incidental hernia < 1 cm)
- Prior hernia repair at laparotomy site
- Use of planar mesh in addition to sutures for closure
- CDC IV dirty or infected wound requiring open abdominal or skin incision
- Life expectancy less than 1 year
- Patient unable or unwilling to provide informed consent
- Patient unable to comply with protocol or follow-up visits
- Patient enrolled in another abdominal wall study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure day
Participants undergo laparotomy closure using either Duramesh or Polydioxanone suture as assigned in the trial.
1 procedure visit (in-person)
Duration - 12 months
Participants are monitored for surgical site events, pain, and satisfaction after surgery, including assessments of device performance and quality of life.
Visits at 1 month and 12 months post-surgery
Trial Site Locations
Total: 1 location
1
UZ Gent
Ghent, Oost-Vlaanderen, Belgium, 9000
Actively Recruiting
Research Team
D
Dorien Haesen, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here